Delivery Order SPE2DE24DA017-SPE2D625F8N36

Award Date 3/24/25
Potential Completion Date 3/27/25
Potential Value $2.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $23,436.00, is for the provision of the ACP MAX PRP SYSTEM (OUS/EU) medical product. The contract is a Fixed Price with Economic Price Adjustment type, and has an ultimate completion date of January 22, 2025. Arthrex Inc., a for-profit Subchapter S Corporation, is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $13,752.00, is for the delivery of the ACP MAX PRP SYSTEM (OUS/EU), a specialized medical device, to support government healthcare systems. The contract has a fixed price with economic price adjustment pricing type and a completion date of May 7, 2025. While this particular delivery order...
This is a $3,635.28 fixed-price delivery order contract awarded to Arthrex Inc., a global medical device manufacturer, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of ACP MAX PRP SYSTEM (W/ ACDA) medical products, which are specialized orthopedic technologies used in minimally invasive procedures. Arthrex holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, which allows VA medical centers nationwide to...
This federal contract award, valued at $1,409.76, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing type, and has an ultimate completion date of March 18, 2025. Arthrex Inc. is...
This federal contract award, valued at $2,387.88, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures headquartered in Naples, Florida. The contract is a Delivery Order for the ACP MAX PRP SYSTEM (OUS/EU), which is a type of Platelet-Rich Plasma (PRP) medical device. The contract is a Fixed Price with Economic Price Adjustment arrangement with a period of performance...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, by the Defense Logistics Agency's Medical Supply Chain. The contract is a Delivery Order valued at $7,920.00 with a fixed price and economic price adjustment pricing type. The award is for the ACP MAX PRP SYSTEM (OUS/EU), a specialized medical device, with an ultimate completion date of April 16, 2025. This contract is not set-aside and is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), a medical device used in orthopedic procedures, with a ceiling value of $15,759.00. The contract is a Fixed Price with Economic Price Adjustment, with a period of performance through March 6, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation...
This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $2,256.60, is for the provision of the ACP MAX PRP SYSTEM (W/O ACDA) medical device. The contract is a fixed-price with economic price adjustment and has an ultimate completion date of January 24, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples,...
This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $4,593.65 fixed-price contract with economic price adjustment is for the ACP MAX PRP SYSTEM (OUS/EU), a specialized medical device used for the extraction and concentration of platelet-rich plasma. Arthrex holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as...
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $5,365.80, is for the provision of ARTHREX ANGEL PRP KITS (US TRAY), a specialized medical device used for platelet-rich plasma therapy. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of April 1, 2025. This contract is...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F8N36
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract has a ceiling value of $2,189.88 and a completion date of March 27, 2025. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), which includes specialized medical devices such as surgical implants, arthroscopic instruments, joint replacement technologies, and platelet-rich plasma kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. The IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This contract is not set aside for any specific business size or socioeconomic category.

Generated 7/1/25, 7:43 AM